Literature DB >> 2396870

Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.

D Logar1, T Kveder, B Rozman, J Dobovisek.   

Abstract

In view of the association of congenital heart block with maternal antibody to cellular antigen Ro (SSA), and one report linking anti-Ro with myocarditis in a patient with myositis an association between anti-Ro antibodies and cardiac disease was sought in adults with systemic lupus erythematosus (SLE). Among 67 patients with SLE, of whom 36 were anti-Ro positive, a significantly higher prevalence of myocarditis and conduction defects was found in the anti-Ro positive group (eight of 36) than in those who were anti-Ro negative (one of 31) and healthy controls (one of 50). Of the 36 anti-Ro positive patients with SLE, three had symptoms diagnostic of myocarditis, and an electrocardiogram showed first degree atrioventricular block and unifascicular block in three cases (including one with myocarditis), right bundle branch block alone (two cases), and first degree atrioventricular block alone (one case). Complete atrioventricular block was not seen. In the anti-Ro negative group there was no myocarditis and only one case of conduction defect (right bundle branch block). Among healthy controls only one of 50 had first degree atrioventricular block. It is concluded that myocarditis and conduction defects are reasonably common in adults with SLE and are associated with anti-Ro antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396870      PMCID: PMC1004179          DOI: 10.1136/ard.49.8.627

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations.

Authors:  R Lowry; J Goguen; C B Carpenter; T B Strom; M R Garovoy
Journal:  Tissue Antigens       Date:  1979-10

2.  Congenital heart block. Anatomic correlations and review of the literature.

Authors:  J B Carter; L C Blieden; J E Edwards
Journal:  Arch Pathol       Date:  1974-01

3.  Complete heart block as the initial manifestation of systemic lupus erythematosus.

Authors:  W P Maier; H E Ramirez; S B Miller
Journal:  Arch Intern Med       Date:  1987-01

4.  Neonatal lupus erythematosus with heart block: family study of a patient with anti-SS-A and SS-B antibodies.

Authors:  M D Lockshin; A Gibofsky; C L Peebles; I Gigli; M Fotino; S Hurwitz
Journal:  Arthritis Rheum       Date:  1983-02

5.  Localization of Ro (SS-A) antigen in the cardiac conduction system.

Authors:  J S Deng; L W Bair; S Shen-Schwarz; R Ramsey-Goldman; T Medsger
Journal:  Arthritis Rheum       Date:  1987-11

6.  Myocardial abscess complicating healed myocardial infarction.

Authors:  S Weisz; D G Young
Journal:  Can Med Assoc J       Date:  1977-05-21       Impact factor: 8.262

7.  Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis.

Authors:  C C Bunn; A E Gharavi; G R Hughes
Journal:  J Clin Lab Immunol       Date:  1982-05

8.  Neonatal lupus erythematosus: five new cases with HLA typing.

Authors:  K A Barber; R Jackson
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

9.  Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins.

Authors:  W M Behan; P O Behan; J Gairns
Journal:  Br Heart J       Date:  1987-02

10.  Cardiovascular abnormalities in systemic lupus erythematosus.

Authors:  B L Chia; E P Mah; P H Feng
Journal:  J Clin Ultrasound       Date:  1981 May-Jun       Impact factor: 0.910

View more
  12 in total

Review 1.  [Cardiovascular manifestations in inflammatory rheumatic diseases].

Authors:  U Lange; J Strunk
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

2.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus.

Authors:  Y Gartshteyn; M Tamargo; S Fleischer; T Kapoor; J Li; A Askanase; R Winchester; L Geraldino-Pardilla
Journal:  Lupus       Date:  2020-01-10       Impact factor: 2.911

4.  Variable atrioventricular block in systemic lupus erythematosus.

Authors:  Sybille Liautaud; Ahmed J Khan; Shireesha R Nalamasu; Irene J Tan; Anekwe E Onwuanyi
Journal:  Clin Rheumatol       Date:  2004-10-26       Impact factor: 2.980

5.  Investigations into Ro-specific antibody-associated congenital cardiac conduction defects.

Authors:  T Dörner; F Hiepe; B Göldner; E Apostoloff
Journal:  Clin Investig       Date:  1992-06

6.  Sub-clinical systemic lupus erythematosus presenting with acute myocarditis.

Authors:  K Sandrasegaran; C W Clarke; V Nagendran
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

7.  A patient of lupus presenting with myocarditis and overlapping autoimmune hepatitis.

Authors:  P Chattopadhyay; D Dhua; C A Philips; J Ghosh
Journal:  Case Rep Rheumatol       Date:  2011-12-12

Review 8.  The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.

Authors:  Maya Guglin; Carson Smith; Roopa Rao
Journal:  Heart Fail Rev       Date:  2020-11-19       Impact factor: 4.214

9.  Clinical characteristics of lupus myocarditis in Korea.

Authors:  Jae-Wook Chung; Dai-Yeol Joe; Han-Jung Park; Hyoun-Ah Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2007-07-19       Impact factor: 3.580

10.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Authors:  A Nandagudi; E C Jury; D Alonzi; T D Butters; S Hughes; D A Isenberg
Journal:  Lupus       Date:  2013-07-17       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.